These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1030 related articles for article (PubMed ID: 27749102)
41. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line. Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970 [TBL] [Abstract][Full Text] [Related]
42. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro. Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664 [TBL] [Abstract][Full Text] [Related]
43. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin. Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101 [TBL] [Abstract][Full Text] [Related]
44. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study. Madane RG; Mahajan HS Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836 [TBL] [Abstract][Full Text] [Related]
45. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery. Zhao Y; Lin D; Wu F; Guo L; He G; Ouyang L; Song X; Huang W; Li X Int J Mol Sci; 2014 Sep; 15(10):17565-76. PubMed ID: 25268623 [TBL] [Abstract][Full Text] [Related]
46. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery. Zhang Y; Zhang P; Zhu T Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584 [TBL] [Abstract][Full Text] [Related]
47. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin. Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323 [TBL] [Abstract][Full Text] [Related]
48. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment. Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415 [TBL] [Abstract][Full Text] [Related]
49. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin. Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002 [TBL] [Abstract][Full Text] [Related]
50. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219 [TBL] [Abstract][Full Text] [Related]
51. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Chen D; Lian S; Sun J; Liu Z; Zhao F; Jiang Y; Gao M; Sun K; Liu W; Fu F Drug Deliv; 2016; 23(3):808-13. PubMed ID: 24892632 [TBL] [Abstract][Full Text] [Related]
52. Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines. Ramachandran C; Nair SM; Escalon E; Melnick SJ J Complement Integr Med; 2012 Aug; 9():Article 20. PubMed ID: 22944718 [TBL] [Abstract][Full Text] [Related]
53. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity. Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128 [TBL] [Abstract][Full Text] [Related]
54. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue. Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349 [TBL] [Abstract][Full Text] [Related]
55. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model. Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445 [TBL] [Abstract][Full Text] [Related]
56. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer. Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302 [TBL] [Abstract][Full Text] [Related]
57. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302 [TBL] [Abstract][Full Text] [Related]
58. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment. Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601 [TBL] [Abstract][Full Text] [Related]
59. Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles. Jiang S; Zhu R; He X; Wang J; Wang M; Qian Y; Wang S Int J Nanomedicine; 2017; 12():167-178. PubMed ID: 28053531 [TBL] [Abstract][Full Text] [Related]
60. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Liu L; Sun L; Wu Q; Guo W; Li L; Chen Y; Li Y; Gong C; Qian Z; Wei Y Int J Pharm; 2013 Feb; 443(1-2):175-82. PubMed ID: 23287774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]